The promoter analysis of the human C17orf25 gene, a novel chromosome 17p13.3 gene

Cell Research

Volumn 12, Issue 5-6, 2002, Pages 339-352

  Guo, Jian Ying ^a   Xu, Jian ^a   Mao, Da Qin ^a   Fu, Li Li ^a   Gu, Jian Ren ^a   Zhu, Jing De ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

Author keywords

C17orf25 gene; Chromosome 17p13.3; SP1; Transcription regulation

Indexed keywords

STAPHYLOCOCCUS PHAGE 3A;

LACTOYLGLUTATHIONE LYASE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHROMOSOME 17; DNA FLANKING REGION; GENE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; LIVER CELL; LIVER CELL CARCINOMA; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOLOGY; PATHOPHYSIOLOGY; PROMOTER REGION; REGULATOR GENE;

5' FLANKING REGION; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 17; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; GENES, REGULATOR; HEPATOCYTES; HUMANS; LACTOYLGLUTATHIONE LYASE; LIVER; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0042737442     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290136     Document Type: Article

References (23)

1. Qin WX, Wan F, Sun FY. Cloning and characterication of a novel gene (C17orf25) from the deletion region on chromosome 17p13.3 in hepatocelular carcinoma. Cell Res 2001; 11(3):209-16.
2. Fujimori M, Tokinom T, Hino O. Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991; 51:89-93.
3. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997; 14:2927-33.
4. Piao Z, Park C, Park JH, Kim H. Allelotype analysis of hepatocellular carcinoma. Int. J. Cancer 1998; 75:29-33.
5. Wang G, Huang CH, Zhao Y. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on c hromosome 16q21-q23 and 9p21-p23. Cell Res 2000; 10:311-23.
6. Ittmann MM. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Prostate 1996; 28(5):275-81.
7. Lothe RA, Fossli T, Danielsen HE. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. J Natl Cancer Inst 1992; 84(14):1100-8.
8. Stack M, Jones D, White G. Detail mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum Mol Genet 1995; 4:2047-55.
9. Zhao XT, Li JJ, He YH. A Novel Growth Suppressor Gene on Chromosome 17p13.3 with a High Frequency of Mutation in Human Hepatocellular Carcinoma. Cancer Res 2001; 61:7383-7.
10. Zhu JD. Myeloidcell-lineage and premylocytic-stage-specific-expression of the mouse myeloperoxidase gene is controlled at initiation as well as elongation levels of transcription. Cell Res 1999; 9:107-34.
11. Smale ST. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochimica et Biophucica Acta 1997; 1351:73-88.
12. Xu J, Zhu JD, Ni M. The ATF/CREB site is the major regulatory element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene. Cell Res 2002; 12:177-97.
13. Zhu JD. FT I, a novel positive myeloid-lineage-specific transcription regulatory element within the mouse myeloperoxidase gene enhancer, En 1. Cell Res 1995; 5:75-91.
14. Ferre F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl 1992; 2(1):1-9.
15. Kashuba VI, Gizatullin RZ, Protopopov AI. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene 1999; 239(2):259-71.
16. Block KL, Shou Y, Thorton M, Poncz M. The regulated expression of a TATA-less, platelet-specific gene, alphaIIb. Stem Cells 1996; 14 Suppl 1:38-47.
17. Wingender E, Chen X, Hehl R.TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000; 28(1):316-9.
18. Cook TB, Gebelein, R Urrutia. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann N Y Acad Sci 1999; 880:94-102.
19. Berg JM. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc Natl Acad Sci USA 1992; 89(23):11109-10.
20. Iguchi-Ariga SM, Schaffner W. CpG methylation of the cAMP-reponsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes and Dev 1989; 3:612-9.
21. Pellegrini M. Computational methods for protein function analysis. Curr Opin Chem Biol 2001; 5(1):46-50.
22. Creighton DJ, Hamilton DS. Brief history of glyoxalase I and what we have learned about metal ion-dependent, enzyme-catalyzed isomerizations. Arch Biochem Biophys 2001; 387(1):1-10.
23. Thornalley PJ. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Interact 1998; 111-112:137-51.